The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smagina I.V.

Otdelenie nevrologii kraevoĭ klinicheskoĭ bolnitsy, Barnaul;
kafedra nervnykh bolezneĭ s kursom nevrologii i refleksoterapii fakulteta povysheniia kvalifikatsii i PPS, Barnaul;
kafedra biokhimii i klinicheskoĭ laboratornoĭ diagnostiki Altaĭskogo gosudarstvennogo meditsinskogo universiteta, Barnaul;
Novosibirskiĭ gosudarstvennyĭ universitet, Novosibirsk

Elchaninova S.A.

Raevskikh V.M.

Environmental risk factors for multiple sclerosis in the population of Altai region

Authors:

Smagina I.V., Elchaninova S.A., Raevskikh V.M.

More about the authors

Read: 816 times


To cite this article:

Smagina IV, Elchaninova SA, Raevskikh VM. Environmental risk factors for multiple sclerosis in the population of Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(9):67‑70. (In Russ.)

Recommended articles:
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38

References:

  1. Boiko A.N., Zavalishin N.A. Rasseyannyi skleroz. V kn.: Nevrologiya: Natsional'noe rukovodstvo. Pod red. E.I. Guseva, A.N. Konovalova, V.I. Skvortsovoi, A.B. Gekht. M: GEOTAR-Media 2010; 909-921.
  2. Gusev E.I., Demina T.L., Boiko A.N. Rasseyannyi skleroz. M: Neft' i gaz 1997; 33-80.
  3. Gusev E.I., Boiko A.K., Smirnova N.F., Demina T.L. Faktory riska razvitiya rasseyannogo skleroza v moskovskoi populyatsii. Zhurn nevrol i psikhiat 1999; 5: 32-40.
  4. Gusev E.I., Boiko A.K., Zavalishin I.A. i dr. Epidemiologicheskie issledovaniya rasseyannogo skleroza: Metodicheskie rekomendatsii M. 2003.
  5. Smagina I.V., El'chaninova S.A., Zolovkina A.G. i dr. Geneticheskie faktory riska rasseyannogo skleroza v populyatsii Altaiskogo kraya. Zhurn nevrol i psikhiat 2011; 5: 42-45.
  6. Fridman M.S. Immunomoduliruyushchie preparaty dlya lecheniya rasseyannogo skleroza: segodnya i v budushchem. Expert Opin Pharmacother 2006; 7: 1-9.
  7. Shmidt T.E., Yakhno N.N. Rasseyannyi skleroz: rukovodstvo dlya vrachei. 2-e izd. M: MEDpress-inform 2010; 272.
  8. Ascherio A. Epstein-Barr virus in the development of multiple sclerosis. Expert Rev Neurotherapeutics 2008; 8: 331-333.
  9. Brankin B. Viruses in MS models. Int MSJ 1995; 2: 50-59.
  10. Compston A., Coles A. Multiple sclerosis. Lanset 2002; 359: 9313: 1221-1719.
  11. Cook S.D., Rohowsky-Kochan C., Bansil S., Dowling P.C. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 1995; 91: 161: 34-42.
  12. Kesselring J., Lassmann H. Pathogenesis. Multiple sclerosis. Ed J Kesselring Cambridge University Press 1997; 54-62.
  13. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurol 1983; 33: 12: 1444-1452.
  14. Lauer K. The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytic study. J Clin Epid 1994; 47: 43-48.
  15. Alpine D., Compston N. Some aspects of the natural history of disseminated sclerosis. QJM 1952; 82: 135-167.
  16. Miller H. Trauma and multiple sclerosis. Lancet 1964; 1: 848-850.
  17. Polman C.H., Reingold S.C., Edan C. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald. Ann Neurol 2005; 56: 840-864.
  18. Poser Ch.M. Trauma to the central nervous system may result in formation or enlargement of multiple sclerosis plaque. Arch Neurol 2000; 57: 1074-1077.
  19. Riise T., Boiko A., Granieri E. et al. The epidemiologic study of etiological factors in multiple sclerosis. Neurology 1997; Special suppl.
  20. Smith G.D., Ben-Shlomo Y. Dietary fat and multiple sclerosis. Int MSJ 1994; 2: 61-67.
  21. Torkildsen O., Nyland H., Myrmel K., Myhr K.M. Epstein-Barr virus reactivation and multiple sclerosis. Eur J Neurol 2008; 15: 1: 106-108.
  22. Warren S., Greenhill S., Warre K.G. Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. J Chron Dis 1982; 35: 821-831.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.